Product List Page 3864

Product ID Product Name CAS# Purity    Y3307066 1,4-Bis(5-ethoxycarbonyl-4-methyl-2-thiazolyl)benzene 1858256-67-3  97% Y3310793 1-[1-(Phenylsulfanyl)-1-(pyridin-2-yl)pentyl]-1H-1,2,3-benzotriazole 159494-10-7  95% Y3306845 1-(9H-Xanthen-9-yl)-1H-benzo[d][1,2,3]triazole 150458-04-1  95% Y3308898 2-tert-Butyl-1-heptyl-4-phenyl-5H,6H-benzo[h]quinolin-1-ium; tetrafluoroboranuide 92540-92-6  95% Y3310344 3-[1-(1H-1,2,3-Benzotriazol-1-yl)ethyl]-1,3-thiazolidine-2-thione 849414-05-7  95% Y3305417 1-[(2E)-3-(Anthracen-9-yl)prop-2-en-1-yl]-1H-1,2,3-benzotriazole 224310-54-7  95% Y3169318 2-[(2-{[(4-Nitrophenoxy)carbonyl]oxy}ethyl)disulfanyl]ethyl 4-nitrophenyl carbonate 1435972-52-3  95% Y3318822 N-Nitroso Desmethyldiphenhydramine 55855-43-1  95% Y3308782 (R)-4-Amino-6-(1-(2-cyano-1-cyclopentylethyl)-1H-pyrazol-4-yl)pyrimidine-5-carboxylic Acid 2606144-44-7  99% Y3304914 1-(1-Benzofuran-2-ylsulfanyl)-3-(1H-1,2,3-benzotriazol-1-yl)propan-2-one 413603-89-1  90% Y3310629 2,5-Diethoxy-4-(propanoyloxy)phenyl propanoate 301171-10-8  98% Y3304822 2-[(2-Methylphenyl)(phenyl)methyl]-2H-1,2,3-benzotriazole 219653-64-2  98% Y3305682 1-(2,4-Dinitrobenzoyl)-1H-1,2,3-benzotriazole 362622-67-1  95% Y3305030 (Z,2E)-2-(1H-1,2,3-Benzotriazol-1-yl)-N-phenylbuta-2-enimidothioic acid 305861-93-2  98% Y3169320 4-Aminopyrazolo[1,5-a]-1,3,5-triazine-8-carboxylic Acid 1550761-16-4  95% Y3308191 Ethyl 3-(phenylsulfonyl)propanoate 10154-73-1  95% Y3307952 1-Benzyl-3-methyl-1H-1,2,3-benzotriazol-3-ium bromide 37922-13-7  98% Y3163472 Tezacaftor-d4 1961280-24-9  97.0% Y3163839 Imlunestrant tosylate 2408840-41-3  98.54% Y3288144 SIC5-6 2410846-16-9  99% Y3163704 (S,R)-GSK321 1816272-18-0  98% Y3291997 OVA (55-62) 151992-56-2  99% Y3307189 JB170 2705844-82-0  98.40% Y3287335 RAS inhibitor Abd-7 2351843-48-4  99% Y3308752 Prodigiosin hydrochloride 56144-17-3  98.00% Y3290490 AD57 1093380-42-7  98% Y3308010 INCB38579 1246207-65-7  99.97% Y3164369 6-Hydrazineylpyrimidine-4-carboxamide 2283190-21-4  95% Y3287610 (6Z,9Z,28Z,31Z)-heptatriaconta-6,9,28,31-tetraen-19-yl 3-(dimethylamino)propanoate 1221271-55-1  98% Y3293262 piCRAC-1 2418049-54-2  98% Y3285913 (Rac)-CP-601927 hydrochloride 230615-01-7  99% Y3305787 (RS)-AMPA monohydrate 76463-67-7  98% Y3296941 HN37 1821222-10-9  99% Y3293239 TRPM8 antagonist 3 2102179-29-1  99% Y3295881 PF-06649298 1854061-16-7  99% Y3287799 Ruzinurad 1638327-48-6  99% Y3169190 AChE-IN-3 2713548-95-7  99% Y3169960 Bromperidol hydrochloride 59453-24-6  99.96% Y3169191 IL-17A inhibitor 1 2452464-73-0  99.87% Y3162305 diABZI-C2-NH2 2137975-93-8  96% Y3286963 RIDR-PI-103 2581114-71-6  98% Y3164527 IL-17A modulator-2 2748749-47-3  99.07% Y3287952 IL-17 modulator 4 2446803-65-0  98% Y3163778 L-Kynurenine-d4 2672568-86-2  99% Y3163700 TLR8 agonist 5 2413016-41-6  96% Y3310459 CU-CPD107 2573912-32-8  98% Y3162280 ALPK1-IN-2 2765633-68-7  98% Y3287850 Rezvilutamide 1572045-62-5  99% Y3167347 5-hydroxy Indole-3-acetic Acid-d6 2748469-82-9  99.0% Y3163723 ZW4864 2632259-93-7  97.08% Y3286235 Angiopeptin TFA 2478421-60-0  99% Y3167348 SOS1-IN-14 2793405-20-4  99% Y3297009 P2Y2R/GPR17 antagonist 1 2395016-49-4  98% Y3164515 Adenosine receptor antagonist 3 2400864-80-2  99% Y3287709 SLF1081851 2763730-97-6  98% Y3290009 Adenosine receptor antagonist 2 2703054-47-9  99% Y3169177 MLN3126 628300-71-0  98.64% Y3288902 Azilsartan mopivabil 2271428-31-8  99% Y3291154 Vornorexant 1517965-94-4  99% Y3287275 CCR8 antagonist 2 2756350-98-6  99% Y3290338 EP3 antagonist 3 1227827-88-4  99% Y3307838 KRpep-2d 2098181-84-9  95.23% Y3294089 (E/Z)-ZINC09659342 591726-26-0  99% Y3286653 (Rac)-Upacicalcet 2649575-19-7  95% Y3164407 KB-5492 free base 113594-64-2  99.06% Y3290754 SOP1812 2546091-70-5  98% Y3293271 Lumefantrine-d9 2477594-24-2  97% Y3294247 Dynole 2-24 1416313-72-8  98% Y3287249 Drp1-IN-1 2247733-08-8  98% Y3162037 CAM833 2758364-02-0  99% Y3163530 MERS-CoV-IN-1 2245697-92-9  99% Y3311259 CWHM-1552 2368253-58-9  100% Y3156239 T-2307 873546-31-7  98.41% Y3169781 Cu-GTSM 68341-14-0  95.0% Y3288766 AZ2 2231760-33-9  99% Y3290106 RMC-6272 2382769-46-0  95% Y3163549 PI3K/Akt/mTOR-IN-2 2757804-89-8  99.86% Y3294569 CYH33 methanesulfonate 1494684-33-1  96% Y3289036 USP30 inhibitor 18 2242582-40-5  99% Y3162225 Vevorisertib trihydrochloride 1416775-08-0  99% Y3294162 TMX-4116 2766385-56-0  99% Y3164312 Intoplicine dimesylate 133711-99-6  98% Y3292293 ATM Inhibitor-5 2495096-26-7  99% Y3161893 DC-U4106 2410534-62-0  99.03% Y3292076 Bezuclastinib 1616385-51-3  98% Y3163614 RORt inverse agonist 23 2230779-18-5  99.34% Y3163714 GNE-0946 1677667-24-1  98% Y3289467 iHCK-37 516478-09-4  99% Y3307151 B-Raf IN 10 1425485-87-5  99% Y3296897 CSF1R-IN-3 2760584-90-3  98% Y3163624 Oritinib 2035089-28-0  99.18% Y3288113 (Rac)-EC5026 1809885-55-9  98% Y3286584 PDE11-IN-1 522652-41-1  98% Y3164379 NG-497 2598242-66-9  98.67% Y3163873 Isovaleryl-DL-carnitine-d9 (chloride) 2608872-54-2  99.72% Y3310197 DP00477 169120-56-3  99% Y3297445 OM-153 2406278-81-5  99% Y3163875 DNMT3A-IN-1 1403598-56-0  98.81% Y3160637 Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH 2750350-39-9  98% Y3163737 (E/Z)-Zotiraciclib hydrochloride 1321626-25-8  99%